Form 4: Inari Medical Director Jonathan Root Reports Acquisition by Stryker, Cash-Out of Shares and RSUs

Director Jonathan Root reports the acquisition of Inari Medical by Stryker Corporation, resulting in the cash-out of his shares and restricted stock units (RSUs) at $80.00 per share.

Summary

• On February 19, 2025, Inari Medical, Inc. was acquired by Stryker Corporation through a merger.
• Each outstanding share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• Jonathan Root, a director of Inari Medical, reported the transaction on a Form 4 filing with the SEC.
• Root's holdings of 541,149 shares of common stock were cashed out at $80.00 per share.
• Additionally, 4,126 restricted stock units (RSUs) held by Root were also cashed out at the same rate.
• The merger was executed under an agreement dated January 6, 2025, with a subsidiary of Stryker merging into Inari Medical, which survived as a wholly-owned subsidiary of Stryker.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The document reports the completion of a merger, which provides a cash-out for shareholders. The lack of negative indicators contributes to the neutral to positive sentiment.

Positives

• Shareholders received $80.00 per share in cash, representing a realized value for their investment.
• The transaction provides immediate liquidity for shareholders.

Future Outlook

Inari Medical is now a wholly-owned subsidiary of Stryker Corporation, and will no longer operate as an independent publicly traded company.

Industry Context

The acquisition of Inari Medical by Stryker reflects ongoing consolidation trends in the medical device industry, where larger companies acquire innovative smaller firms to expand their product portfolios and market reach.

Comparison to Industry Standards

• Acquisitions in the medical device industry often involve a premium paid to the target company's shareholders.
• The $80.00 per share cash consideration should be compared to Inari Medical's trading price prior to the announcement to assess the premium received.
• Comparable acquisitions in the medical device space include [hypothetical example] Medtronic's acquisition of Mazor Robotics, which also involved a significant cash premium.

Stakeholder Impact

• Shareholders received cash consideration for their shares.
• Employees of Inari Medical are now part of Stryker Corporation.
• The acquisition may impact Inari Medical's customers and suppliers as the company integrates into Stryker's operations.

Key Dates

Keywords

Inari Medical, Stryker, Merger, Acquisition, Jonathan Root, Form 4, SEC Filing, Cash-out, RSUs, Shareholder Value